drugset / Trial / NCT02056184

Targeted Ultrasound in Rheumatoid Arthritis

NCT02056184

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether therapy modifications (including addition of ultrasound-guided treatment change) can change imaging results in patients with early rheumatoid arthritis in a stable clinical disease activity state.

Timeline

Start
2013-12
Primary completion
2017-12
Completion
2019-07

Drugs

EvaluationDrugModalityDoseRoute
Background Adalimumab Monoclonal antibody

Indications